DUBLIN, May 1, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Human Embryonic Stem Cells (hESC) Market Analysis By Application (Regenerative Medicines, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Country (U.S., UK, Germany, Japan, China), And Segment Forecasts, 2014 - 2025" report to their offering.

The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025

Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.

Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.

In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.

Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.

However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.

Further Key Findings from the Report Suggest:

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Human Embryonic Stem Cells Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.1.1 Market Driver Analysis 3.1.1.1 Technological advancement involving stem cells therapy 3.1.1.2 Rising demand for regenerative medicines 3.1.1.3 R&D in toxicology testing 3.1.1.4 Technological advanvcements for the production of embryonic stem cells through alternative methods 3.1.1.5 Increasing prevalence of genetic disorders 3.1.2 Market Restraint Analysis 3.1.2.1 Ethical concern related to stem cell research 3.2 Penetration & Growth Prospect Mapping for Application, 2015 3.3 Human embryonic stem cells -Swot Analysis, By Factor (Political & Legal, Economic And Technological) 3.4 Industry Analysis - Porter's

4 Human Embryonic Stem Cells Market: Application Estimates & Trend Analysis 4.1 Global Human Embryonic Stem Cells Market: Application Movement Analysis 4.2 Regenerative Medicine 4.3 Stem Cell Biology Research 4.4 Tissue Engineering 4.5 Toxicology Testing

5 Human Embryonic Stem Cells Market: Regional Estimates & Trend Analysis, by Application

6 Competitive Landscape 6.1 Strategy Framework 6.2 Market Participation Categorization 6.3 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/cnx9vb/human_embryonic

Media Contact:

Research and Markets Laura Wood, Senior Manager rel="nofollow">press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-human-embryonic-stem-cells-hesc-market-analysis-2014-2017--2025-key-players-are-cellgenix-international-stem-cell-thermo-fisher-scientific-kite-pharma-promocell-and-lonza-300448137.html

SOURCE Research and Markets

The rest is here:
Research and Markets - Global Human Embryonic Stem Cells ... - Markets Insider